Searched for
BIOASIA 2026
Dr Reddy's readies day-1 launch of semaglutide genericDr Reddy's Laboratories is set to launch a generic version of semaglutide in India on March 21. The company plans to offer both oral and in...- CM Revanth Reddy pitches Telangana as biopharma investment destinationTelangana is inviting global investors to its life sciences sector. Chief Minister A Revanth Reddy pledges partnership for success. The sta...
- Eli Lilly could launch obesity drug in India next year, CEO saysEli Lilly plans to launch its diabetes and obesity drug, Mounjaro, in India next year. The drug contains tirzepatide and is sold as Zepboun...
- Load More